These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24780944)
21. [New considerations in the treatment of functional dyspepsia]. Herszényi L; Juhász M; Tulassay Z Orv Hetil; 2004 Apr; 145(14):747-54. PubMed ID: 15131990 [TBL] [Abstract][Full Text] [Related]
22. Dyspepsia consulters and patterns of management: a population-based study. Ahlawat SK; Richard Locke G; Weaver AL; Farmer SA; Yawn BP; Talley NJ Aliment Pharmacol Ther; 2005 Aug; 22(3):251-9. PubMed ID: 16091063 [TBL] [Abstract][Full Text] [Related]
23. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it. Lieder A; Issing W Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545 [No Abstract] [Full Text] [Related]
24. Improvement of gastrointestinal quality of life scores in cases of Helicobacter pylori-positive functional dyspepsia after successful eradication therapy. Suzuki H; Masaoka T; Sakai G; Ishii H; Hibi T J Gastroenterol Hepatol; 2005 Nov; 20(11):1652-60. PubMed ID: 16246181 [TBL] [Abstract][Full Text] [Related]
25. Update on the evaluation and management of functional dyspepsia. Loyd RA; McClellan DA Am Fam Physician; 2011 Mar; 83(5):547-52. PubMed ID: 21391521 [TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitors for dyspepsia. Vakil N Dig Dis; 2008; 26(3):215-7. PubMed ID: 18463438 [TBL] [Abstract][Full Text] [Related]
27. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study. Sun J; Yuan YZ; Holtmann G Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464 [TBL] [Abstract][Full Text] [Related]
28. Symptoms in patients on long-term proton pump inhibitors: prevalence and predictors. Raghunath AS; Hungin AP; Mason J; Jackson W Aliment Pharmacol Ther; 2009 Feb; 29(4):431-9. PubMed ID: 19035981 [TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial. Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937 [TBL] [Abstract][Full Text] [Related]
30. Usefulness of famotidine in functional dyspepsia patient treatment: comparison among prokinetic, acid suppression and antianxiety therapies. Seno H; Nakase H; Chiba T Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():32-6. PubMed ID: 15943844 [TBL] [Abstract][Full Text] [Related]
31. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Talley NJ; Tack J; Ptak T; Gupta R; Giguère M Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059 [TBL] [Abstract][Full Text] [Related]
32. [A plant extract and its modified preparation in functional dyspepsia. Results of a double-blind placebo controlled comparative study]. Madisch A; Melderis H; Mayr G; Sassin I; Hotz J Z Gastroenterol; 2001 Jul; 39(7):511-7. PubMed ID: 11505331 [TBL] [Abstract][Full Text] [Related]
33. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia. Sawant P; Das HS; Desai N; Kalokhe S; Patil S J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356 [TBL] [Abstract][Full Text] [Related]
34. Common Gastrointestinal Symptoms: dyspepsia and Helicobacter pylori. Fashner J; Gitu AC FP Essent; 2013 Oct; 413():24-8. PubMed ID: 24124704 [TBL] [Abstract][Full Text] [Related]
35. Treatment of uninvestigated dyspepsia with cisapride for patients with negative Helicobacter pylori serologies. Kearney DJ; Avins AL; McQuaid KR Am J Gastroenterol; 2000 Sep; 95(9):2212-7. PubMed ID: 11007220 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of the natural antioxidant astaxanthin in the treatment of functional dyspepsia in patients with or without Helicobacter pylori infection: A prospective, randomized, double blind, and placebo-controlled study. Kupcinskas L; Lafolie P; Lignell A; Kiudelis G; Jonaitis L; Adamonis K; Andersen LP; Wadström T Phytomedicine; 2008 Jun; 15(6-7):391-9. PubMed ID: 18467083 [TBL] [Abstract][Full Text] [Related]
37. A prospective study of oesophageal 24-h ambulatory pH monitoring in patients with functional dyspepsia. Gerson LB; Triadafilopoulos G Dig Liver Dis; 2005 Feb; 37(2):87-91. PubMed ID: 15733519 [TBL] [Abstract][Full Text] [Related]
38. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study. Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968 [TBL] [Abstract][Full Text] [Related]
39. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial. van Zanten SV; Armstrong D; Chiba N; Flook N; White RJ; Chakraborty B; Gasco A Am J Gastroenterol; 2006 Sep; 101(9):2096-106. PubMed ID: 16817845 [TBL] [Abstract][Full Text] [Related]
40. A non-interventional, observational study of a fixed combination of pepsin and amino acid hydrochloride in patients with functional dyspepsia. Forssmann K; Meier L; Uehleke B; Breuer C; Stange R BMC Gastroenterol; 2017 Nov; 17(1):123. PubMed ID: 29178842 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]